Hurdle approached Catalyst Solutions to explore a potential R&D claim relating to one specific area of their work. While they had previously submitted R&D Tax Relief claims, they were looking to revisit a portion of their innovation pipeline with fresh technical input.<\/span>\u00a0<\/span><\/p>\n During early discussions, the Catalyst Solutions technical team worked closely with their internal experts to unpack the full scope of activity,\u00a0identifying\u00a0five qualifying projects across three scientific fields, including in vitro diagnostics and epigenetic diagnostics.<\/span>\u00a0<\/span><\/p>\n Chronomics needed a partner who could engage at the level of the science. The work spanned multiple disciplines and required close collaboration with both scientific and finance teams to bring structure and clarity to a complex process.<\/p>\n Catalyst Solution’s technical team worked closely with Hurdle’s internal experts to map the full scope of their R&D activity, identifying five qualifying projects across three scientific fields.<\/strong> From there, Catalyst worked alongside the finance team to structure the claim in a way that maximised benefit while keeping risk tightly managed.<\/p>\n <\/p>\n Hurdle came into the engagement expecting qualifying R&D expenditure of around \u00a31 million. The detailed technical review told a different story.<\/p>\n \u00a37m+ in qualifying R&D expenditure identified across three scientific fields.<\/p><\/blockquote>\n This resulted in a claim seven times larger than originally anticipated.<\/p>\n \u00a32m+ cash benefit secured and reinvested into Hurdle’s research programme.<\/p><\/blockquote>\n","protected":false},"featured_media":8730,"parent":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"class_list":["post-8722","case-studies","type-case-studies","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n
\n<\/h4>\n
Why Catalyst Solutions<\/h4>\n
<\/h4>\n
The Approach<\/h4>\n
The Outcome<\/h4>\n